Skip to main content
logo
Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.4096
+0.0236 (6.11%)
Aug 14, 2026, 2:23 PM EDT - Market open

Werewolf Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
21-1.8919.9416.4-
Revenue Growth
---90.55%21.60%--
Gross Profit
-5.19-41.73-51.2-18.96-34.56-33.98
Operating Income
-25.57-60.68-73.59-40.5-56.06-50.09
Net Income
-34.61-60.82-70.52-37.37-53.81-201.93
Earnings Per Share
-0.75-1.33-1.63-1.05-1.86-10.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
21.9957.05111134.34129.32157.53
Total Debt
-37.6737.0951.9214.6815.66
Net Cash (Debt)
21.9919.3873.9182.42114.63141.87
Net Cash Growth
-45.64%-73.78%-10.33%-28.10%-19.20%57.58%
Net Cash Per Share
0.460.411.692.313.977.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-30.15-60.29-56.19-32.61-40.6-42.88
Capital Expenditures
---0.25-0.77-3.61-0.5
Free Cash Flow
-30.15-60.29-56.44-33.38-44.21-43.37
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-24.69%---95.09%-210.69%-
Operating Margin
-121.78%--3904.19%-203.09%-341.78%-
Pretax Margin
-164.82%--3740.85%-187.37%-328.09%-
Profit Margin
-164.82%--3740.85%-187.37%-328.09%-
FCF Margin
-143.56%--2994.27%-167.38%-269.54%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.89-34.997.013.84-